Kolinpharma S.p.A.

BIT:KIP 株式レポート

時価総額:€15.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Kolinpharma マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Rita Petrelli

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間3.8yrs

経営陣の近況

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

CEO(最高経営責任者

Rita Petrelli

no data

在職期間

Dr. Rita Paola Petrelli is the Co-Founder, Chairwoman of The Board, Chief Executive Officer and Chief Financial Officer of Kolinpharma S.p.A. Dr. Petrelli is chartered accountant, auditor and technical-leg...


取締役

名称ポジション在職期間報酬所有権
Rita Petrelli
Co-Founderno dataデータなしデータなし
Massimo Mantella
CEO & Director4.4yrsデータなしデータなし
Francesco Spano
Independent Directorno dataデータなしデータなし
Pierluigi Pipolo
Chairman of the Board of Statutory Auditors3.8yrsデータなしデータなし
Giannunzio Corazza
Non-Executive Directorno dataデータなしデータなし
Edoardo Ferragina
Non-Executive Directorno dataデータなしデータなし
Maurizio Altini
Independent Directorno dataデータなしデータなし
Giulio Centemero
Standing Auditor3.8yrsデータなしデータなし
Roberto Giannella
Standing Auditor3.8yrsデータなしデータなし

3.8yrs

平均在職期間

経験豊富なボード: KIPの 取締役会経験豊富 であると考えられます ( 3.8年の平均在任期間)。